These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 21994207)
1. Enhancement of carboplatin- and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells. Sharma A; Bhat MK Integr Cancer Ther; 2011 Dec; 10(4):NP4-14. PubMed ID: 21994207 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Hsp27 and Hsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells. Sharma A; Upadhyay AK; Bhat MK Cancer Biol Ther; 2009 Nov; 8(22):2106-13. PubMed ID: 19901540 [TBL] [Abstract][Full Text] [Related]
3. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis. Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993 [TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma. Lim SC; Choi JE; Kang HS; Han SI Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331 [TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells. Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802 [TBL] [Abstract][Full Text] [Related]
7. Regulation of p53-, Bcl-2- and caspase-dependent signaling pathway in xanthorrhizol-induced apoptosis of HepG2 hepatoma cells. Handayani T; Sakinah S; Nallappan M; Pihie AH Anticancer Res; 2007; 27(2):965-71. PubMed ID: 17465228 [TBL] [Abstract][Full Text] [Related]
8. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564 [TBL] [Abstract][Full Text] [Related]
9. VI-16, a newly synthesized flavonoid, induces apoptosis through the mitochondrial pathway in human hepatoma cells. Lu N; Wei L; Gong D; Gao Y; Dai Q; Li Z; Guo Q Oncol Rep; 2012 Mar; 27(3):873-9. PubMed ID: 22179765 [TBL] [Abstract][Full Text] [Related]
10. New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin. Brito AF; Ribeiro M; Abrantes AM; Mamede AC; Laranjo M; Casalta-Lopes JE; Gonçalves AC; Sarmento-Ribeiro AB; Tralhão JG; Botelho MF Nutr Cancer; 2016; 68(2):250-66. PubMed ID: 26943884 [TBL] [Abstract][Full Text] [Related]
11. Isatis indigotica induces hepatocellular cancer cell death via caspase-independent apoptosis-inducing factor translocation apoptotic pathway in vitro and in vivo. Chung YC; Tang FY; Liao JW; Chung CH; Jong TT; Chen SS; Tsai CH; Chiang EP Integr Cancer Ther; 2011 Jun; 10(2):201-14. PubMed ID: 21382959 [TBL] [Abstract][Full Text] [Related]
12. Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells. Yan F; Wang M; Li J; Cheng H; Su J; Wang X; Wu H; Xia L; Li X; Chang HC; Li Q Environ Toxicol Pharmacol; 2012 Mar; 33(2):181-90. PubMed ID: 22222560 [TBL] [Abstract][Full Text] [Related]
13. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430 [TBL] [Abstract][Full Text] [Related]
14. Jiedu Xiaozheng Yin decoction inhibits hepatoma cell proliferation by inducing apoptosis via the mitochondrial-mediated pathway. Cao Z; Chen X; Lin W; Zhao J; Zheng L; Ye H; Liao L; Du J Mol Med Rep; 2015 Aug; 12(2):2800-6. PubMed ID: 25936398 [TBL] [Abstract][Full Text] [Related]
15. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro. Chen YL; Yan MY; Chien SY; Kuo SJ; Chen DR; Cheng CY; Su CC Mol Med Rep; 2013 May; 7(5):1487-93. PubMed ID: 23525225 [TBL] [Abstract][Full Text] [Related]
16. Dulxanthone A induces cell cycle arrest and apoptosis via up-regulation of p53 through mitochondrial pathway in HepG2 cells. Tian Z; Shen J; Moseman AP; Yang Q; Yang J; Xiao P; Wu E; Kohane IS Int J Cancer; 2008 Jan; 122(1):31-8. PubMed ID: 17847033 [TBL] [Abstract][Full Text] [Related]
17. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Brenes O; Arce F; Gätjens-Boniche O; Díaz C Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942 [TBL] [Abstract][Full Text] [Related]
18. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells. Wu SJ; Ng LT; Lin CC Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126 [TBL] [Abstract][Full Text] [Related]
19. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model. Abdel-Hamid NI; El-Azab MF; Moustafa YM Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612 [TBL] [Abstract][Full Text] [Related]
20. Hyperthermia-associated carboplatin resistance: differential role of p53, HSF1 and Hsp70 in hepatoma cells. Sharma A; Meena AS; Bhat MK Cancer Sci; 2010 May; 101(5):1186-93. PubMed ID: 20180806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]